Reported By:
| Edited By: KV Ramana |Source: DNA |Updated: Mar 30, 2018, 04:15 AM IST
Teva Pharmaceutical Industries and Dr Reddy’s Laboratories have announced the commercial launch of olanzapine tablets, the generic version of Eli Lilly’s Zyprexa. Zyprexa (olanzapine) is used to treat psychotic conditions such as schizophrenia and bipolar disorder. Annual sales of Zyprexa are around $3.2 billion in the US, based on IMS sales data.
Teva’s olanzapine tablets in 2.5 mg, 5 mg, 7.5 mg, 10 mg and 15 mg and Dr Reddy’s olanzapine tablets in 20 mg have each been awarded a 180-day period of marketing exclusivity in the US.
Dr Reddy’s is supplying the 20 mg version of the product following an April 2011 supply agreement with Teva.
